BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34357100)

  • 1. Clinical Impact of Pre-Procedural Percutaneous Coronary Intervention in Low- and Intermediate-Risk Transcatheter Aortic Valve Replacement Recipients.
    Winter MP; Hofbauer TM; Bartko PE; Nitsche C; Koschutnik M; Kammerlander AA; Donà C; Spinka G; Spinka F; Andreas M; Mach M; Rosenhek R; Lang IM; Mascherbauer J; Hengstenberg C; Goliasch G
    J Pers Med; 2021 Jul; 11(7):. PubMed ID: 34357100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary revascularization during treatment of severe aortic stenosis: A meta-analysis of the complete percutaneous approach (PCI plus TAVR) versus the complete surgical approach (CABG plus SAVR).
    Tarus A; Tinica G; Bacusca A; Artene B; Popa IV; Burlacu A
    J Card Surg; 2020 Aug; 35(8):2009-2016. PubMed ID: 32667080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes and revascularization strategies in patients with low-flow, low-gradient severe aortic valve stenosis according to the assigned treatment modality.
    O'Sullivan CJ; Englberger L; Hosek N; Heg D; Cao D; Stefanini GG; Stortecky S; Gloekler S; Spitzer E; Tüller D; Huber C; Pilgrim T; Praz F; Buellesfeld L; Khattab AA; Carrel T; Meier B; Windecker S; Wenaweser P
    JACC Cardiovasc Interv; 2015 Apr; 8(5):704-17. PubMed ID: 25946444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: Real-world results from the East Denmark Heart Registry.
    Millan-Iturbe O; Sawaya FJ; Lønborg J; Chow DHF; Bieliauskas G; Engstrøm T; Søndergaard L; De Backer O
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):818-826. PubMed ID: 29214718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Coronary Artery Disease Severity Assessed With the SYNTAX Score on Outcomes Following Transcatheter Aortic Valve Replacement.
    Paradis JM; White JM; Généreux P; Urena M; Doshi D; Nazif T; Hahn R; George I; Khalique O; Harjai K; Lasalle L; Labbé BM; DeLarochellière R; Doyle D; Dumont É; Mohammadi S; Leon MB; Rodés-Cabau J; Kodali S
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Effects of Coronary Disease Severity and Completeness of Revascularization on Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Witberg G; Regev E; Chen S; Assali A; Barbash IM; Planer D; Vaknin-Assa H; Guetta V; Vukasinovic V; Orvin K; Danenberg HD; Segev A; Kornowski R
    JACC Cardiovasc Interv; 2017 Jul; 10(14):1428-1435. PubMed ID: 28728656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Coronary Artery Disease on Postoperative Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR): Is Preoperative Coronary Revascularization Necessary?
    Chauhan D; Thawabi M; Haik N; Haik BJ; Chen C; Cohen M; Russo M
    J Invasive Cardiol; 2016 Dec; 28(12):E179-E184. PubMed ID: 27922809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of residual coronary atherosclerosis on transfemoral transcatheter aortic valve replacement.
    Li J; Patel SM; Nadeem F; Thakker P; Al-Kindi S; Thomas R; Makani A; Hornick JM; Patel T; Lipinski J; Ichibori Y; Davis A; Markowitz AH; Bezerra HG; Simon DI; Costa MA; Kalra A; Attizzani GF
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):545-552. PubMed ID: 30312990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN-TAVI registry.
    Guedeney P; Tchétché D; Petronio AS; Mehilli J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Iadanza A; Sardella G; Van Mieghem NM; Sorrentino S; Claessen BEPM; Chandrasekhar J; Vogel B; Kalkman DN; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Ferrer-Grazia MC; Naber C; Kievit P; Baber U; Sharma S; Morice MC; Chieffo A; Mehran R;
    Catheter Cardiovasc Interv; 2019 May; 93(6):1124-1131. PubMed ID: 30511802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment and management of coronary artery disease in patients undergoing transcatheter aortic valve replacement.
    Prabhakar M; Liu S; Bagai A; Yanagawa B; Verma S; Cheema AN
    Curr Opin Cardiol; 2020 Sep; 35(5):540-547. PubMed ID: 32649355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in Patients With Transcatheter Aortic Valve Replacement and Left Main Stenting: The TAVR-LM Registry.
    Chakravarty T; Sharma R; Abramowitz Y; Kapadia S; Latib A; Jilaihawi H; Poddar KL; Giustino G; Ribeiro HB; Tchetche D; Monteil B; Testa L; Tarantini G; Facchin M; Lefèvre T; Lindman BR; Hariri B; Patel J; Takahashi N; Matar G; Mirocha J; Cheng W; Tuzcu ME; Sievert H; Rodés-Cabau J; Colombo A; Finkelstein A; Fajadet J; Makkar RR
    J Am Coll Cardiol; 2016 Mar; 67(8):951-960. PubMed ID: 26916485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial.
    Reardon MJ; Heijmen RH; Van Mieghem NM; Williams MR; Yakubov SJ; Watson D; Kleiman NS; Conte J; Chawla A; Hockmuth D; Petrossian G; Robinson N; Kappetein AP; Li S; Popma JJ
    JAMA Cardiol; 2019 Aug; 4(8):810-814. PubMed ID: 31215985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of coronary artery disease in patients undergoing transcatheter aortic valve replacement: Insights from the FRANCE-2 registry.
    Puymirat E; Didier R; Eltchaninoff H; Lung B; Collet JP; Himbert D; Durand E; Leguerrier A; Leprince P; Fajadet J; Teiger E; Chevreul K; Lièvre M; Tchetché D; Leclercq F; Chassaing S; Le Breton H; Donzeau-Gouge P; Lefèvre T; Carrié D; Gillard M; Blanchard D
    Clin Cardiol; 2017 Dec; 40(12):1316-1322. PubMed ID: 29247516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Coronary Artery Disease on 30-Day and 1-Year Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: A Meta-Analysis.
    Sankaramangalam K; Banerjee K; Kandregula K; Mohananey D; Parashar A; Jones BM; Jobanputra Y; Mick S; Krishnaswamy A; Svensson LG; Kapadia SR
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29021275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To revascularize or not before transcatheter aortic valve implantation?
    Perez S; Thielhelm TP; Cohen MG
    J Thorac Dis; 2018 Nov; 10(Suppl 30):S3578-S3587. PubMed ID: 30505538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter aortic valve replacement- management of patients with significant coronary artery disease undergoing aortic valve interventions: surgical compared to catheter-based approaches in hybrid procedures.
    Baumbach H; Schairer ER; Wachter K; Rustenbach C; Ahad S; Stan A; Hill S; Bramlage P; Franke UFW; Schäufele T
    BMC Cardiovasc Disord; 2019 May; 19(1):108. PubMed ID: 31088373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice.
    Van Mieghem NM; van der Boon RM; Faqiri E; Diletti R; Schultz C; van Geuns RJ; Serruys PW; Kappetein AP; van Domburg RT; de Jaegere PP
    JACC Cardiovasc Interv; 2013 Aug; 6(8):867-75. PubMed ID: 23871511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter aortic valve replacement and percutaneous coronary intervention versus surgical aortic valve replacement and coronary artery bypass grafting in patients with severe aortic stenosis and concomitant coronary artery disease: A systematic review and meta-analysis.
    Kotronias RA; Bray JH; Scarsini R; Rajasundaram S; Terentes-Printzios D; De Maria GL; Kharbanda RK; Mamas MA; Bagur R; Banning AP
    Catheter Cardiovasc Interv; 2020 Nov; 96(5):1113-1125. PubMed ID: 32662594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant percutaneous coronary intervention and transcatheter aortic valve replacement: safe and feasible replacement alternative approaches in high-risk patients with severe aortic stenosis and coronary artery disease.
    Salhab KF; Al Kindi AH; Lane JH; Knudson KE; Kapadia S; Roselli EE; Tuzcu ME; Svensson LG
    J Card Surg; 2013 Sep; 28(5):481-3. PubMed ID: 23869423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.